WO1998030696A3 - Proteines secretees et polynucleotides les codant - Google Patents

Proteines secretees et polynucleotides les codant Download PDF

Info

Publication number
WO1998030696A3
WO1998030696A3 PCT/US1998/000575 US9800575W WO9830696A3 WO 1998030696 A3 WO1998030696 A3 WO 1998030696A3 US 9800575 W US9800575 W US 9800575W WO 9830696 A3 WO9830696 A3 WO 9830696A3
Authority
WO
WIPO (PCT)
Prior art keywords
polynucleotides encoding
secreted proteins
proteins
secreted
polynucleotides
Prior art date
Application number
PCT/US1998/000575
Other languages
English (en)
Other versions
WO1998030696A2 (fr
WO1998030696A8 (fr
Inventor
Kenneth Jacobs
John M Mccoy
Edward R Lavallie
Lisa A Racie
David Merberg
Michael J Agostino
Original Assignee
Genetics Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/783,395 external-priority patent/US5945302A/en
Priority claimed from PCT/US1997/005682 external-priority patent/WO1997038084A2/fr
Application filed by Genetics Inst filed Critical Genetics Inst
Priority to JP53122198A priority Critical patent/JP2002513280A/ja
Priority to CA002278104A priority patent/CA2278104A1/fr
Priority to EP98901784A priority patent/EP1007660A2/fr
Priority to AU58223/98A priority patent/AU5822398A/en
Publication of WO1998030696A2 publication Critical patent/WO1998030696A2/fr
Publication of WO1998030696A3 publication Critical patent/WO1998030696A3/fr
Publication of WO1998030696A8 publication Critical patent/WO1998030696A8/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Transplantation (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Nouveaux polynucléotides et protéines codées par ceux-ci.
PCT/US1998/000575 1997-01-13 1998-01-13 Proteines secretees et polynucleotides les codant WO1998030696A2 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP53122198A JP2002513280A (ja) 1997-01-13 1998-01-13 分泌蛋白およびそれらをコードするポリヌクレオチド
CA002278104A CA2278104A1 (fr) 1997-01-13 1998-01-13 Proteines secretees et polynucleotides les codant
EP98901784A EP1007660A2 (fr) 1997-01-13 1998-01-13 Proteines secretees et polynucleotides les codant
AU58223/98A AU5822398A (en) 1997-01-13 1998-01-13 Secreted proteins and polynucleotides encoding them

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US08/783,395 1997-01-13
US08/783,395 US5945302A (en) 1996-04-05 1997-01-13 Polynucleotides encoding secreted proteins
PCT/US1997/005682 WO1997038084A2 (fr) 1996-04-05 1997-04-04 Polynucleotides codant des proteines secretees
JPPCT/US97/05682 1997-04-04
US86602297A 1997-05-30 1997-05-30
US08/866,022 1997-05-30
US08/924,838 US5972652A (en) 1996-04-05 1997-09-05 Polynucleotides encoding secreted proteins
US08/924,838 1997-09-05
US598698A 1998-01-12 1998-01-12
US09/005,986 1998-01-12

Publications (3)

Publication Number Publication Date
WO1998030696A2 WO1998030696A2 (fr) 1998-07-16
WO1998030696A3 true WO1998030696A3 (fr) 1998-10-29
WO1998030696A8 WO1998030696A8 (fr) 1999-08-26

Family

ID=56289818

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1998/000575 WO1998030696A2 (fr) 1997-01-13 1998-01-13 Proteines secretees et polynucleotides les codant

Country Status (5)

Country Link
EP (1) EP1007660A2 (fr)
JP (1) JP2002513280A (fr)
AU (1) AU5822398A (fr)
CA (1) CA2278104A1 (fr)
WO (1) WO1998030696A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1047713A4 (fr) * 1998-01-12 2001-05-30 Genetics Inst Proteines secretees et polynucleotides codant ces proteines
CA2363684A1 (fr) * 1999-03-05 2000-09-08 Incyte Pharmaceuticals, Inc. Proteines de secretion humaines
WO2006085482A1 (fr) * 2005-02-10 2006-08-17 Riken Facteur d'autoreplication et procede d’amplification d’une cellule souche hematopoietique

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990005780A1 (fr) * 1988-11-18 1990-05-31 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University Recepteurs de dopamine et genes
WO1990014432A1 (fr) * 1989-05-23 1990-11-29 Genetics Institute, Inc. Une cytokine humaine, l'interleukine 9
EP0510691A1 (fr) * 1991-04-26 1992-10-28 Osaka Bioscience Institute ADN codant un antigène de surface cellulaire humaine
WO1994007916A1 (fr) * 1992-10-07 1994-04-14 Merck & Co., Inc. Recepteur d'hormone steroide humain neri
WO1996017925A1 (fr) * 1994-12-06 1996-06-13 Immunex Corporation Cytokine designee par lerk-7
US5536637A (en) * 1993-04-07 1996-07-16 Genetics Institute, Inc. Method of screening for cDNA encoding novel secreted mammalian proteins in yeast
WO1997007198A2 (fr) * 1995-08-11 1997-02-27 Genetics Institute, Inc. Sequences d'adn et proteines secretees codees par celles-ci
WO1997038084A2 (fr) * 1996-04-05 1997-10-16 Genetics Institute, Inc. Polynucleotides codant des proteines secretees
WO1998004693A2 (fr) * 1996-07-26 1998-02-05 Genetics Institute, Inc. Proteines secretees et polynucleotides les codant

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990005780A1 (fr) * 1988-11-18 1990-05-31 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University Recepteurs de dopamine et genes
WO1990014432A1 (fr) * 1989-05-23 1990-11-29 Genetics Institute, Inc. Une cytokine humaine, l'interleukine 9
EP0510691A1 (fr) * 1991-04-26 1992-10-28 Osaka Bioscience Institute ADN codant un antigène de surface cellulaire humaine
WO1994007916A1 (fr) * 1992-10-07 1994-04-14 Merck & Co., Inc. Recepteur d'hormone steroide humain neri
US5536637A (en) * 1993-04-07 1996-07-16 Genetics Institute, Inc. Method of screening for cDNA encoding novel secreted mammalian proteins in yeast
WO1996017925A1 (fr) * 1994-12-06 1996-06-13 Immunex Corporation Cytokine designee par lerk-7
WO1997007198A2 (fr) * 1995-08-11 1997-02-27 Genetics Institute, Inc. Sequences d'adn et proteines secretees codees par celles-ci
WO1997038084A2 (fr) * 1996-04-05 1997-10-16 Genetics Institute, Inc. Polynucleotides codant des proteines secretees
WO1998004693A2 (fr) * 1996-07-26 1998-02-05 Genetics Institute, Inc. Proteines secretees et polynucleotides les codant

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
ADAMS M D ET AL: "3,400 NEW EXPRESSED SEQUENCE TAGS IDENTIFY DIVERSITY OF TRANSCRIPTS IN HUMAN BRAIN", NATURE GENETICS, vol. 4, no. 3, pages 256 - 267, XP000611495 *
C. AUFFRAY ET AL.: "H. sapiens partial cDNA sequence; clone c-0ja07", EMBL SEQUENCE DATABASE, 5 November 1994 (1994-11-05), HEIDELBERG, FRG, XP002060223 *
JACOBS K ET AL: "A novel method for isolating eukaryotic cDNA clones encoding secreted proteins.", KEYSTONE SYMPOSIUM ON DENDRITIC CELLS: ANTIGEN PRESENTING CELLS OF T AND B LYMPHOCYTES, TAOS, NEW MEXICO, USA, MARCH 10-16, 1995. JOURNAL OF CELLULAR BIOCHEMISTRY SUPPLEMENT 0 (21A). 1995. 19. ISSN: 0733-1959, XP002027246 *
L. HILLIER ET AL.: "zd68f10.r1 Soares fetal heart NbHH19W Homo sapiens cDNA clone 345835 5'", EMBL SEQUENCE DATABASE, 25 June 1996 (1996-06-25), HEIDELBERG, FRG, XP002060222 *
R.J. KAUFMAN ET AL.: "Effect of von Willebrand factor coexpression on the synthesis and secretion of factor VIII in chinese hamster ovary cells", MOL. CELL. BIOL., vol. 9, no. 3, March 1989 (1989-03-01), ASM WASHINGTON, DC,US, pages 1233 - 1242, XP002041592 *
R.J. KAUFMAN ET AL.: "Improved vectors for stable expression of foreign genes in mammalian cells by use of the untranslated leader sequence from EMC virus", NUCLEIC ACIDS RESEARCH, vol. 19, no. 16, 1991, IRL PRESS LIMITED,OXFORD,ENGLAND, pages 4485 - 4490, XP002041594 *
R.J. KAUFMAN ET AL.: "The phosphorylation state of eucaryotic initiation factor 2 alters translation efficiency of specific mRNAs", MOL. CELL. BIOL., vol. 9, no. 3, March 1989 (1989-03-01), ASM WASHINGTON, DC,US, pages 946 - 958, XP002041593 *

Also Published As

Publication number Publication date
JP2002513280A (ja) 2002-05-08
CA2278104A1 (fr) 1998-07-16
WO1998030696A2 (fr) 1998-07-16
AU5822398A (en) 1998-08-03
EP1007660A2 (fr) 2000-06-14
WO1998030696A8 (fr) 1999-08-26

Similar Documents

Publication Publication Date Title
WO1998007859A3 (fr) Proteines secretees et polynucleotides codant lesdites proteines
WO1998017687A3 (fr) Proteines secretees et polynucleotides codant ces proteines
WO1997007198A3 (fr) Sequences d'adn et proteines secretees codees par celles-ci
WO1999057132A8 (fr) Proteines secretees et polynucleotides codant pour celles-ci
WO1998033916A3 (fr) Proteines secretees et polynucleotides codant celles-ci
WO1998042739A3 (fr) Proteines secretees et polynucleotides les codant
WO1998042741A3 (fr) Proteines secretees et polynucleotides les codant
WO1998004693A3 (fr) Proteines secretees et polynucleotides les codant
WO1998055614A3 (fr) Proteines secretees et polynucleotides codant ces proteines
WO2001075068A3 (fr) Proteines secretee et polynucleotides codant pour ces proteines
WO1998040486A3 (fr) Proteines secretees et polynucleotides les codant
WO1998005776A3 (fr) Proteines secretees et polynucleotides codant ces proteines
WO1998027205A3 (fr) Proteines secretees et polynucleotides codant pour lesdites proteines
WO1999058642A3 (fr) Proteines secretees et polynucleotides codant pour ces dernieres
WO1998046757A3 (fr) Proteines secretees et polynucleotides codant ces proteines
WO1998037094A3 (fr) Proteines secretees et polynucleotides les codant
WO1998032853A3 (fr) Proteines secretees et polynucleotides les codant
AU6553898A (en) Human secreted protein, ba3.1, and polynucleotides encoding same
WO1998040404A3 (fr) Proteines secretees et polynucleotides codant ces dernieres
WO1998056909A3 (fr) Proteines secretees et polynucleotides les codant
WO1998030589A3 (fr) Proteines secretees et polynucleotides les codant
WO1998041539A3 (fr) Proteines secretees et polynucleotides les codant
WO1998021332A3 (fr) Proteines secretes et polynucleotides les codant
WO1998038209A3 (fr) Proteines secretees et polynucleotides codant pour celles-ci
WO1998031802A3 (fr) Proteines secretees et polynucleotides codant ces proteines

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SZ UG ZW AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SZ UG ZW AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL

121 Ep: the epo has been informed by wipo that ep was designated in this application
ENP Entry into the national phase

Ref document number: 2278104

Country of ref document: CA

Ref country code: CA

Ref document number: 2278104

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 1998901784

Country of ref document: EP

AK Designated states

Kind code of ref document: C1

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: C1

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i

Free format text: PAT. BUL. 28/98 UNDER (30) REPLACE "08/783395 13.01.97 AP" BY "08/783395 13.01.97 US"

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 1998901784

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1998901784

Country of ref document: EP